Hossam Nada

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 19

Top Topics

Molecular Docking

Tyrosine Kinase

Oxidative Stress

Top Venues

Medicinal research reviews

International journal of molecular sciences

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Dipesh S Harmalkar, Aneesh Sivaraman, Hossam Nada, Joohan Lee, Hyeseul Kang, Yongseok Choi, Kyeong Lee
Natural products as IL-6 inhibitors for inflammatory diseases: Synthetic and SAR perspective. Medicinal research reviews 44 (4) (2024)
Dipesh S Harmalkar, Aneesh Sivaraman, Hossam Nada, Joohan Lee, Hyeseul Kang, Yongseok Choi, Kyeong Lee
Natural products as IL-6 inhibitors for inflammatory diseases: Synthetic and SAR perspective. Medicinal research reviews 44 (4) (2024)
Dipesh S Harmalkar, Aneesh Sivaraman, Hossam Nada, Joohan Lee, Hyeseul Kang, Yongseok Choi, Kyeong Lee
Natural products as IL-6 inhibitors for inflammatory diseases: Synthetic and SAR perspective. Medicinal research reviews 44 (4) (2024)
Dipesh S Harmalkar, Aneesh Sivaraman, Hossam Nada, Joohan Lee, Hyeseul Kang, Yongseok Choi, Kyeong Lee
Natural products as IL-6 inhibitors for inflammatory diseases: Synthetic and SAR perspective. Medicinal research reviews (2024)
Hossam Nada, Sungdo Kim, Suin Park, Moo Yeol Lee, Kyeong Lee
Identification of Potent hDHODH Inhibitors for Lung Cancer via Virtual Screening of a Rationally Designed Small Combinatorial Library. ACS omega 8 (24) (2023)
Sreenivasulu Godesi, Hossam Nada, Joohan Lee, Joon-Hee Kang, Soo-Youl Kim, Yongseok Choi, Kyeong Lee
Integration of Hybridization Strategies in Pyridine-Urea Scaffolds for Novel Anticancer Agents: Design, Synthesis, and Mechanistic Insights. Molecules (Basel, Switzerland) 28 (13) (2023)
Hossam Nada, Sungdo Kim, Suin Park, Moo Yeol Lee, Kyeong Lee
Identification of Potent hDHODH Inhibitors for Lung Cancer via Virtual Screening of a Rationally Designed Small Combinatorial Library. ACS omega 8 (24) (2023)
Sreenivasulu Godesi, Joohan Lee, Hossam Nada, Guofeng Quan, Ahmed Elkamhawy, Yongseok Choi, Kyeong Lee
Small Molecule c-KIT Inhibitors for the Treatment of Gastrointestinal Stromal Tumors: A Review on Synthesis, Design Strategies, and Structure-Activity Relationship (SAR). International journal of molecular sciences 24 (11) (2023)
Hossam Nada, Anam Rana Gul, Ahmed Elkamhawy, Sungdo Kim, Minkyoung Kim, Yongseok Choi, Tae Jung Park, Kyeong Lee
Machine Learning-Based Approach to Developing Potent EGFR Inhibitors for Breast Cancer-Design, Synthesis, and In Vitro Evaluation. ACS omega 8 (35) (2023)
Sreenivasulu Godesi, Jeong-Ran Han, Jang-Keun Kim, Dong-Ik Kwak, Joohan Lee, Hossam Nada, Minkyoung Kim, Hyun-A Yang, Joo-Young Im, Hyun Seung Ban, Chang Hoon Lee, Yongseok Choi, Misun Won, Kyeong Lee
Design, Synthesis and Biological Evaluation of Novel MDH Inhibitors Targeting Tumor Microenvironment. Pharmaceuticals (Basel, Switzerland) 16 (5) (2023)
Kwanshik Lee, Hossam Nada, Minkyoung Kim, Hyejun Park, Kiho Lee, Dongho Seo, Kyeong Lee, Yongseok Choi
Cantharidin-Based Verbenone Derivatives as a Novel Insecticide against Plutella xylostella : Design, Synthesis, Insecticidal Activity Evaluation, and 3D QSAR Study. Biomolecules 13 (8) (2023)
Hossam Nada, Ahmed Elkamhawy, Kyeong Lee
Identification of 1H-purine-2,6-dione derivative as a potential SARS-CoV-2 main protease inhibitor: molecular docking, dynamic simulations, and energy calculations. PeerJ 10 (2022)
Hossam Nada, Ahmed Elkamhawy, Magda H Abdellatif, Andrea Ageli, Chang Hoon Lee, Claudiu T Supuran, Kyeong Lee
4-Anilinoquinazoline-based benzenesulfonamides as nanomolar inhibitors of carbonic anhydrase isoforms I, II, IX, and XII: design, synthesis, in-vitro , and in-silico biological studies. Journal of enzyme inhibition and medicinal chemistry 37 (1) (2022)
Ahmed Elkamhawy, Jiyu Woo, Hossam Nada, Andrea Ageli, Dong Keun Han, Claudiu T Supuran, Kyeong Lee
Identification of Novel and Potent Indole-Based Benzenesulfonamides as Selective Human Carbonic Anhydrase II Inhibitors: Design, Synthesis, In Vitro, and In Silico Studies. International journal of molecular sciences 23 (5) (2022)
Mohamed H Elsherbeny, Ahmed Elkamhawy, Hossam Nada, Magda H Abdellatif, Kyeong Lee, Eun Joo Roh
Development of New Meridianin/Leucettine-Derived Hybrid Small Molecules as Nanomolar Multi-Kinase Inhibitors with Antitumor Activity. Biomedicines 9 (9) (2021)
Ahmed Elkamhawy, Jiyu Woo, Noha A Gouda, Jushin Kim, Hossam Nada, Eun Joo Roh, Ki Duk Park, Jungsook Cho, Kyeong Lee
Melatonin Analogues Potently Inhibit MAO-B and Protect PC12 Cells against Oxidative Stress. Antioxidants (Basel, Switzerland) 10 (10) (2021)
Kyeong Lee, Hossam Nada, Hyun Jung Byun, Chang Hoon Lee, Ahmed Elkamhawy
Hit Identification of a Novel Quinazoline Sulfonamide as a Promising EphB3 Inhibitor: Design, Virtual Combinatorial Library, Synthesis, Biological Evaluation, and Docking Simulation Studies. Pharmaceuticals (Basel, Switzerland) 14 (12) (2021)
Ahmed Elkamhawy, Qili Lu, Hossam Nada, Jiyu Woo, Guofeng Quan, Kyeong Lee
The Journey of DDR1 and DDR2 Kinase Inhibitors as Rising Stars in the Fight Against Cancer. International journal of molecular sciences 22 (12) (2021)
Hossam Nada, Ahmed Elkamhawy, Kyeong Lee
Structure Activity Relationship of Key Heterocyclic Anti-Angiogenic Leads of Promising Potential in the Fight against Cancer. Molecules (Basel, Switzerland) 26 (3) (2021)